[Clinical studies of ceftibuten in the field of obstetrics and gynecology].
Clinical studies on ceftibuten (CETB, 7432-S) were carried out in the field of obstetrics and gynecology. A total of 6 patients comprising 1 case of endometritis, 3 of bartholin's abscess, 1 of adnexitis and 1 of vulvar abscess was given 200-300 mg of CETB divided into 2 or 3 equal oral doses daily for 5 days. The clinical efficacy rate was 83 percent. Neither adverse reactions nor abnormal laboratory values were observed in any of the cases. From the results, it was concluded that CETB was an useful antibiotic in the field of obstetrics and gynecology.
Doko
F
F
Department of Obstetrics and Gynecology, Hiroshima City Hospital.
D000284:Administration, Oral; D000328:Adult; D002214:Capsules; D000077722:Ceftibuten; D002511:Cephalosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D004716:Endometritis / Q000188:drug therapy; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy
D002214:Capsules; D002511:Cephalosporins; D000077722:Ceftibuten